Biome Australia logo

Biome Australia(ASX) BIO

Market CapA$93.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+238%
5 YearN/A
1 Year-13%
1 Month+13%
A$0.41
+1.25%
+0.01Today
Biome Australia last closing stock price
MetricPriceDate
Last closeAUD 0.412026-10-09
Biome Australia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.57%AUD 0.422026-10-02
1 month+12.5%AUD 0.362026-09-09
3 month+50%AUD 0.272026-07-10
Year to date-3.57%AUD 0.422025-12-31
1 year-12.9%AUD 0.472025-10-09
3 year+189.29%AUD 0.142023-10-10
Since inception+237.5%AUD 0.122021-11-30

Biome Australia Financials at a Glance

Market Cap

A$93.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$42.30M

Net Income (TTM)

A$3.82M

EPS (TTM)

A$0.02

P/E Ratio

25.00

Dividend

A$0.00

Beta (Volatility)

-0.04 (Low)

Price

A$0.41

Volume

56,421

Open

A$0.41

Previous Close

A$0.41

Daily Range

A$0.40 - A$0.41

52-Week Range

A$0.20 - A$0.51

Estimated Earnings Date

Feb 23, 2027

BIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biome Australia

Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products. The company offers a diverse product line, including live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance.

Products and Services
  • Live biotherapeutics under the Activated Probiotics brand
  • Organic nutritional supplements branded as Activated Nutrients
  • Athletic performance and recovery products named Activated X Performance
Growth Outlook
  • Recent quarterly revenue reached AUD 11.48 million, indicating strong market demand
  • Trailing twelve months (TTM) revenue shows a growth trend with a gross profit margin of 61%
  • Current ratio of 2.12 suggests strong liquidity and operational efficiency
Financial Highlights
  • Net income for the latest quarter was AUD 2.43 million, reflecting a net profit margin of 21%
  • Operating income increased to AUD 1.12 million, demonstrating improved operational performance
  • Return on equity (ROE) stands at 46.74%, indicating effective use of shareholder funds
Biome Australia Limited is positioned in the healthcare sector, focusing on innovative health solutions. The company's commitment to quality and efficacy in its product offerings has contributed to its growing reputation in the market. With a solid financial foundation and a diverse product range, Biome Australia Limited is well-equipped to capitalize on the increasing demand for health and wellness products. The recent financial performance highlights a positive trajectory, making it an intriguing option for potential investors interested in the pharmaceutical industry.
AI Generated • Sep 25, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Blair William Brabin Vega Norfolk

Website

biomeaustralia.com

Headquarters

Collingwood, VIC 3066, AU

BIO Financials

Key Financial Metrics (TTM)

Gross Margin

61.06%

Operating Margin

7.53%

Net Income Margin

15.11%

Return on Equity

46.74%

Return on Capital

14.56%

Return on Assets

22.96%

Earnings Yield

4.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$93.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

231.41M

Volume

56.42K

Avg. Volume

229.35K

Financials (TTM)

Gross Profit

A$25.84M

Operating Income

A$2.08M

EBITDA

A$2.39M

Operating Cash Flow

-A$1.19M

Capital Expenditure

-A$241.51K

Free Cash Flow

-A$1.43M

Cash & ST Invst.

A$3.55M

Total Debt

A$2.97M

Biome Australia Performance Analysis

Biome Australia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 7,235,61175.5%
20242024-06-30AUD 13,008,89779.8%
20252025-06-30AUD 18,417,18841.6%
20262026-06-30AUD 23,883,24029.7%
Biome Australia sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3126.8%
Q42025-06-307.8%
Q22025-12-3129.8%
Q42026-06-30-7.4%
Biome Australia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-32.6%
20242024-06-30AUD -0.01-47.7%
20252025-06-30AUD 0.00N/A
20262026-06-30AUD 0.021490.0%
Biome Australia sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31371.4%
Q42025-06-30-152.6%
Q22025-12-31620.0%
Q42026-06-30105.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$11.48M

+64.2%

Gross Profit

A$7.15M

+71.4%

Gross Margin

62.26%

N/A

Market Cap

A$93.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$3.12M

N/A

Employees

30

N/A

Net Income

A$2.43M

+1779.0%

EBITDA

A$1.33M

+2359.6%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$3.55M

+23.8%

Total Debt

A$2.97M

+128.9%

Accounts Receivable

A$3.73M

+30.1%

Inventory

A$3.98M

+110.6%

Long Term Debt

A$807.30K

+381.1%

Short Term Debt

A$2.16M

+91.5%

Return on Assets

22.96%

N/A

Return on Invested Capital

17.52%

N/A

Free Cash Flow

-A$620.10K

-228.9%

Operating Cash Flow

-A$458.95K

-193.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VLS.AXVita Life Sciences Limited
A$2.78+0.00%
S66.AXStar Combo Pharma Limited
A$0.14+0.00%
HCT.AXHolista Colltech Limited
A$0.05+16.28%
EZZ.AXEZZ Life Science Holdings Limited
A$0.36+2.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About BIO

What is the current price of Biome Australia?

Biome Australia is trading at A$0.41 per share.

What is the 52-week range for Biome Australia?

Over the past 52 weeks, Biome Australia has traded between A$0.20 and A$0.51.

How much debt does Biome Australia have?

As of the most recent reporting period, Biome Australia reported total debt of A$2.97M.

How much cash does Biome Australia have on hand?

Biome Australia reported A$3.55M in cash and cash equivalents in its most recent financial results.

What is Biome Australia’s dividend yield?

Biome Australia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services